欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）

MR编号	SE/H/2265/001
药品名称	Abacavir/Lamivudine Medical Valley
活性成分	abacavir 600.0 mg lamivudine 300.0 mg
剂型	Film-coated tablet
上市许可持有人	Medical Valley Invest AB Brädgardsvägen 28 SE-23632, Höllviken Sweden
参考成员国 - 产品名称	Sweden (SE)
互认成员国 - 产品名称	Denmark (DK)
许可日期	2017/12/21
最近更新日期	2023/12/27
药物ATC编码	J05AR02 lamivudine and abacavir
申请类型	TypeLevel1：[not specified] TypeLevel2：[not specified] TypeLevel3：[not specified] TypeLevel4：[not specified] TypeLevel5：[not specified]
附件文件下载	PAR Summary \| Abacavir Lamivudine Medical Valley 600 300 mg film_coated tablet ENG sPARDate of last change:2022/05/14 PAR \| Abacavir Lamivudine Medical Valley 600 300 mg film_coated tablet ENG PARDate of last change:2022/05/14 Final Product Information \| common-pl-cleanDate of last change:2021/05/07 Final Product Information \| common-spc-clean_2Date of last change:2021/05/07 Final SPC \| common-spc-cleanDate of last change:2021/05/07 Final SPC \| common-spc-trackedDate of last change:2021/05/07 Final PL \| common-pl-trackedDate of last change:2021/05/07 Final PL \| common-pl-cleanDate of last change:2021/05/07 Final Labelling \| common-interpack-blisterpvcpvdcDate of last change:2019/03/27 Final Labelling \| common-interpack-blisteralualuDate of last change:2019/03/27 Final Labelling \| common-interpack-bottleDate of last change:2019/03/27
市场状态	Positive